Quick Answer
Outlook Therapeutics, Inc. reported Shares Outstanding of 53.89 million shares for fiscal year 2025.
Outlook Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 53.89M | +125.4% |
| 2024 | 23.91M | +83.7% |
| 2023 | 13.01M | -94.3% |
| 2022 | 227.31M | +28.8% |
| 2021 | 176.46M | +38.7% |
| 2020 | 127.18M | +344.5% |
| 2019 | 28.61M | +216.9% |
| 2018 | 9.03M | -63.8% |
| 2017 | 24.93M | +9.3% |
| 2016 | 22.80M | +141.6% |
| 2015 | 9.44M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 64.56M | +159.2% | +19.8% |
| September 30, 2025 | 53.89M | +125.4% | +23.9% |
| June 30, 2025 | 43.48M | +85.8% | +32.1% |
| March 31, 2025 | 32.91M | +49.5% | +32.1% |
| December 31, 2024 | 24.91M | -90.4% | +4.2% |
| September 30, 2024 | 23.91M | +83.7% | +2.1% |
| June 30, 2024 | 23.41M | -91.0% | +6.3% |
| March 31, 2024 | 22.01M | -91.4% | -91.5% |
- Outlook Therapeutics, Inc. showed an increase of +125.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2025 period, Outlook Therapeutics, Inc.’s shares outstanding has grown by 471.1% (from 9.44 million shares to 53.89 million shares).
- The most recent figure is from Outlook Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 19, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: